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Malignant transformation of mouse skin by chemical
carcinogens and tumor promoters, such as the phor-
bol ester 12-O-tetradecanoylphorbol-13-acetate, is a
multistage process leading to the formation of
squamous cell carcinomas. In an effort to identify
target genes whose expression is associated with skin
tumorigenesis we combined elements of suppression
subtractive hybridization with differential screening
to isolate genes that are differentially upregulated in
mouse skin after short-term treatment with 12-O-
tetradecanoylphorbol-13-acetate and that exhibit a
high constitutive expression in squamous cell carci-
nomas. Here, we report the detailed analysis of one
of these cDNAs encoding the serine protease BSSP in
mouse skin. Phorbol ester application increases BSSP
expression in keratinocytes of the epidermis and
the hair follicle several-fold starting 4 h post-
treatment. Transcriptional activation of BSSP by
12-O-tetradecanoylphorbol-13-acetate was found to
be independent of c-Fos expression and resistant to
downregulation by glucocorticoids. By monitoring
BSSP expression throughout experimental skin carci-
nogenesis we found strong constitutive expression in
hyperplastic epidermis as well as in proliferatively
active keratinocytes of benign and malignant skin
tumors. These results establish a novel link between
expression of an as yet ill-de®ned serine protease
and skin carcinogenesis. Key words: AP-1/epidermis/
multistage skin carcinogenesis/tumor promoter/suppression
subtraction hybridization. J Invest Dermatol 117:634±640,
2001
T
umorigenesis represents a complex multistage process
in which genetic changes and environmental factors
are thought to deregulate the cellular processes that
control cell proliferation and differentiation. To
provide reliable diagnostic markers and to develop
novel therapeutic avenues for cancer treatment an understanding of
the molecular basis of skin tumors, as well as other cancer types,
will be essential, particularly the identi®cation and functional
characterization of cellular genes that are targeted by oncogenic
stimuli.
One class of transcription factors that mediates gene regulation in
response to radiation, chemical carcinogens, tumor promoters, and
oncoproteins is the activator protein 1 (AP-1) family (Angel and
Karin, 1991). AP-1 represents a plethora of dimeric complexes
composed of members of Jun, Fos, and ATF proteins. Gain-of-
function approaches, both in tissue culture cells and in mice, have
established the ability of Jun and Fos to induce cell transformation
upon overexpression. Furthermore, ®broblasts lacking Fos or Jun
proteins cannot be transformed by oncoproteins, such as Ras and
Src (Angel and Karin, 1991; Wisdom, 1999). Most importantly,
AP-1 subunits have been proven to contribute to premalignant
conversion and malignant progression of epidermal cells in the
initiation-promotion protocol of mouse multistage skin carcino-
genesis, which ranks among the best studied in vivo approaches in
experimental cancer research (Greenhalgh et al, 1990; Dong et al,
1994; Yuspa et al, 1994; Brown and Balmain, 1995; Joseloff and
Bowden, 1997). In particular, in mice lacking c-fos the development
of malignant skin tumors from papillomas is blocked at the
transition from the benign to the malignant state (Saez et al, 1995).
Moreover, transgenic mice expressing a transdominant-negative
version of c-Jun (TAM67) are resistant to 7,12-dimethylbenz[a]an-
thracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)
induced skin tumorigenesis (Young et al, 1999).
The critical role of AP-1 in skin carcinogenesis is also supported
by the increased expression level of two ``classical'' AP-1 target
genes, stromelysin-1/matrix metalloproteinase 3 (MMP-3) and
collagenase-3/MMP-13, in squamous cell carcinoma (SCC)
(D'Armiento et al, 1995; Sternlicht et al, 1999; Tuckermann and
Breitenbach, unpublished). In line with these data, expression of
both genes can be rapidly induced more than 100-fold in mouse
skin upon treatment with the phorbol ester TPA (Tuckermann et
al, 1999). Interestingly, cotreatment of mouse skin with gluco-
corticoids blocks both phorbol-ester-mediated multistage carcino-
genesis (Slaga, 1984; Budunova et al, 1997) and transcriptional
upregulation of MMP-3 and MMP-13 in skin, possibly by mutual
interference between the glucocorticoid receptor and AP-1 (Karin,
1998; Tuckermann et al, 1999). In addition to AP-1, however,
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other transcription factors that synergize with AP-1, such as NFkB
(Stein et al, 1993), become activated in skin by TPA (Budunova et
al, 1999), suggesting that genetic programs regulated directly or
indirectly by AP-1, as well as AP-1-independent target genes,
contribute to the process of skin carcinogenesis.
In order to identify novel genes that may contribute to neoplastic
skin growth we used suppression subtraction hybridization (SSH)
to create a library of TPA-inducible genes in mouse skin. These
cDNA clones were characterized by reverse northern blot analysis
using complex cDNA probes derived from SCC to select for genes
that exhibit high basal level expression at late stages of skin
carcinogenesis.
In this study, we report the detailed analysis of a newly identi®ed
TPA-inducible cDNA clone, identical to the 3¢ end of a recently
described serine protease BSSP expressed in murine brain and skin
(Meier et al, 1999). We observed high levels of BSSP transcripts
after phorbol ester treatment of murine skin and throughout the
multistage carcinogenesis process in skin, relative to untreated
control tissue. These data suggest that BSSP may be involved in the
process of skin carcinogenesis by virtue of its serine protease activity
involved directly or indirectly in the alteration of the local
environment to support tumor cell growth and invasion.
MATERIALS AND METHODS
Animals Female C57BL/6 mice aged 7±9 wk and female NMRI mice
(RCC, FuÈllinsdorf, Switzerland) as well as c-fos
±/± mice (Wang et al,
1992) were housed in speci®c pathogen free and light, temperature
(21°C), and humidity (50%±60% relative humidity) controlled
conditions. Food and water were available ad libitum. The procedures for
performing animal experiments were in accordance with the principles
and guidelines of the ATBW (of®cials for animal welfare) and were
approved by the RegierungspraÈsidium Karlsruhe.
Treatment of mouse skin C67BL/6 and c-Fos±/± mice as well as
their littermates were shaved on the dorsal skin and treated 3 d later
topically with 10 nmol TPA, which is the dose used for the promotion
of skin tumors (Marks and FuÈrstenberger, 1990), or with 10 nmol TPA
plus 50 mg dexamethasone (Sigma Chemical) dissolved in 200 ml
acetone. The animals were sacri®ced 0±16 h after TPA application.
Hyperplastic skin was obtained from female NMRI mice. Three days
before start of treatment 7-wk-old animals were shaved; subsequently,
for a period of 7 wk single doses of 10 nmol TPA were dissolved in
acetone and applied twice a week onto the dorsal skin. Four days after
the last TPA application the animals were sacri®ced and the skin was
taken. Skin tumors derived from female NMRI mice used in this study
were generated according to the initiation-promotion protocol of
chemically induced multistage carcinogenesis (FuÈrstenberger and Kopp-
Schneider, 1995). All tissues and tumors were isolated and immediately
frozen in liquid nitrogen.
Isolation of poly(A)+ RNA and cDNA synthesis Total RNA was
isolated from acetone-control skin and 6 h TPA-treated mouse dorsal
skin using RNeasy (AGS, Heidelberg, Germany) according to the
manufacturer's recommendation. Poly(A)+ RNA was puri®ed using
oligo(dT) coated Quiaex beads (Quiagen, Hilden, Germany). To
synthesize double-stranded cDNA aliquots of 2 mg poly(A)+ RNA with
500 ng oligo(dT)-RsaI primer adapter (Clontech, Palo Alto, CA) in a
volume of 11 ml were heated to 70°C for 10 min in a thermal cycler
(Perkin Elmer 2400) and rapidly chilled on ice. The reaction mixture
was made up to 20 ml by adding 4 ml 5 3 ®rst-strand buffer (provided
with the Superscript reverse transcriptase; Gibco BRL, Karlsruhe,
Germany), 2 ml 0.1 M dithiothreitol, and 1 ml dNTP mix (10 mM each
dATP, dGTP, dCTP, and dTTP). Reverse transcription was started by
adding 2 ml reverse transcriptase and incubating for 1 h. Subsequently,
Klenow-mediated second-strand cDNA synthesis was performed
according to the instructions of the PCR-SelectÔ cDNA subtraction kit
(Clontech).
Generation of a subtracted library using SSH SSH was performed
between cDNA from acetone-control skin (``tester'') and 6 h TPA-
treated mouse dorsal skin (``driver'') using the PCR-Select cDNA
subtraction kit (Clontech) according to the manufacturer's
recommendation, except for modi®cations of the polymerase chain
reaction (PCR) and hybridization conditions. All PCR and hybridization
steps were performed on a Perkin Elmer 2400 thermal cycler. For the
®rst hybridization the mixture of ``driver'' and ``tester'' cDNAs was
denatured at 100°C for 20 s and then cooled over 1 min to 68°C and
maintained at this temperature for 8 h. For the second hybridization, a
2-fold excess of control ``driver'' cDNA (von Stein et al, 1997) was
denatured at 100°C for 20 s and then added directly to the pooled mix
of the two previous hybridizations and allowed to incubate at 68°C for
20 h. It was necessary to alter the PCR conditions (see below) such that
the ampli®cation of unaltered sequences was kept to a minimum. All
other procedures for generation of the subtracted library were done
according to the guidelines of the cDNA subtraction kit. PCR
parameters were as follows: 20 cycles of 94°C for 20 s, 68°C for 30 s,
and 72°C for 2 min. The subtracted cDNA was subjected to a second
round of PCR (nested), using the same PCR conditions with the
exception that 14 cycles were performed. The subtracted cDNA library
was cloned directly into the T/A vector pCRII.1 (TA cloning kit,
Invitrogen, De Schelp, Netherlands) and the ligation was transformed
into Electromax bacterial strain DH10B (Life Science, Karlsruhe,
Germany).
Reverse northern high density blot analysis A total of 3000
individual recombinant clones were picked and individually inoculated
into sterile 96-well microtiter plates containing LB-medium and
ampicillin at 100 mg per ml. After incubation of bacteria on a gyratory
shaker for 8 h at 37°C, equal amounts of the liquid cultures were spotted
in duplicate onto nylon membranes (Hybond N+, Amersham Pharmacia,
Freiburg, Germany). The ®lters were hybridized under stringent
conditions (7% sodium dodecyl sulfate in 0.5 M NaPO4, pH 7.2) at
65°C overnight with equivalent amounts of 32P- labeled double-stranded
cDNA probes derived from acetone-control ``driver'' and 6 h TPA-
treated murine dorsal skin ``tester'' mRNA, respectively, which were
prepared according to the recommendation of Roche Diagnostics'
cDNA synthesis kit (Roche Diagnostics, Mannheim, Germany). Filters
were washed under stringent conditions at 65°C. The ®lters were
exposed to X-ray ®lm up to 2 d at ±80°C and the signals of
corresponding clones were compared. The complex ``driver'' and
``tester'' cDNA probes were also used for southern blot analysis of
EcoRI-digested plasmid of selected cDNA clones.
Northern blot analysis Total RNA was isolated from cell lines, from
6 h acetone-control, TPA-treated, and TPA-plus-dexamethasone-treated
murine skin, and from SCC, as described previously (Tuckermann et al,
1999). Fifteen micrograms total RNA were fractionated on 1.4%
formaldehyde-agarose gels and subjected to northern blot analysis using
an [a-32P]dCTP-labeled BSSP cDNA insert (nucleotides 608±1095 of
the published BSSP sequence; Meier et al, 1999), which was isolated by
EcoRI digestion of the appropriate pCRII.1-plasmid. The probe for 18S
rRNA was obtained by reverse transcription PCR using RNA from
mouse skin.
In situ hybridization In situ hybridization was performed on 6 mm
paraf®n sections as described in detail previously (Gack et al, 1995). All
the samples were ®xed in 4% paraformaldehyde and treated with
proteinase K (0.3 mg per ml); subsequently they were washed in 0.1 M
triethanolamine buffer containing 0.25% acetic anhydride. The sections
were covered with 20±100 ml of hybridization buffer containing
1.5 3 106 cpm of 35S-labeled antisense or sense RNA probe, and
incubated at 53°C for 18 h in a humidi®ed chamber. After hybridization,
the slides were washed under stringent conditions (50% formamide,
65°C), including treatment with RNAse A (20 mg per ml) to remove
unhybridized probe. After 7±21 d of autoradiography, the photographic
emulsion (NTB2; Kodak, MuÈnchen, Germany) was developed, and the
slides were stained with hematoxylin and eosin. Each sample was
hybridized in at least two experiments. BSSP cRNA probe was derived
by in vitro transcription from a HindIII linearized recombinant plasmid
pCRII.1 containing a 487 bp fragment (nucleotides 608±1095 of the
published BSSP sequence; Meier et al, 1999). As a control for
nonspeci®c hybridization, sections were hybridized with 35S-labeled
sense RNA from the pCRII.1 plasmid linearized with BamHI.
Immunohistochemistry Six micron thick paraf®n sections from skin
biopsies were treated as described previously (Schnarr et al, 2000)
followed by incubation with anti-proliferative cellular nuclear antigen
(anti-PCNA) antibodies (10 mg per ml ®nal concentration; DAKO,
Hamburg, Germany) for 16 h at 4°C. After thorough rinsing with
50 mM Tris-buffer (pH 7.4) sections were incubated with 18 mg per ml
goat antirabbit IgG (Dianova, Hamburg, Germany) followed by two
cycles of incubation with a 1:10 diluted mouse alkaline phosphatase±
antialkaline phosphatase complex (APAAP; Linaris, MuÈnchen, Germany).
After washing with distilled water for 5 min, sections were incubated
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with naphthol AS-BI phosphate (Sigma, MuÈnchen, Germany) as
substrate and stained with fuchsin (Sigma) as chromogen. Blocking of the
endogenous alkaline phosphatase was achieved by adding 1.73 mM
levamisol (Sigma).
RESULTS
Cloning of phorbol-ester-inducible genes from mouse
skin Recently, we established in vivo conditions to induce rapid
alterations in gene expression of the well-known AP-1 target genes
MMP-3 and MMP-13 in mouse skin by phorbol esters
(Tuckermann et al, 1999). In order to identify novel phorbol-
ester-inducible genes we used this experimental set-up to apply
SSH using poly(A)+ RNA from murine skin 6 h after treatment
with TPA. Three thousand clones of the generated subtractive
library were spotted onto nylon membranes. Comparative
hybridization analysis identi®ed 400 clones highly upregulated in
TPA-treated mouse skin (data not shown; examples of a
rehybridization of selected clones are shown in Fig 1). These
cDNAs were derived from 76 unique known and 25 unknown
genes. To select for TPA-inducible genes highly expressed at late
stages of carcinogenesis, reverse northern blot hybridization using a
complex cDNA probe derived from pooled SCC was performed.
As shown in Fig 1, some of the TPA-inducible genes, such as
metallothionein Ia (lane 7), did not exhibit enhanced expression in
SCC. This additional screening procedure led to the identi®cation
of ®ve unknown cDNAs, which are derived from genes that are
highly expressed in SCC. Moreover, 29 cDNAs of known genes
were isolated including established AP-1-regulated genes, such as
the virus-like retrotransposon VL30 (Fig 1, lane 3) or the small
proline rich protein (SPRR) 1A (data not shown). VL30 and
SPRR1A have been previously documented to be overexpressed in
SCC (French and Norton, 1997; Tesfaigzi and Carlson, 1999). One
of these clones (Fig 1, lane 15) was found to be identical to the 3¢
end of the recently described serine protease BSSP (Meier et al,
1999). As this gene has not yet been associated with the process of
skin carcinogenesis, and in light of the proposed function of
members of the protein family of serine proteases, this clone was
chosen for further analysis.
Regulation of BSSP expression in TPA-treated mouse
skin To examine the time course of phorbol-ester-mediated
transcriptional activation of BSSP, mouse skin was treated with
TPA for different time periods. Northern blot analysis revealed a
strong increase in the abundance of the 1.3 kb BSSP message
detectable 4 h after treatment reaching maximal levels 12±16 h
post-stimulation (Fig 2 and data not shown), resembling the
expression pro®le described for known AP-1 target genes such as
MMP-3 and MMP-13 in mouse skin (Tuckermann et al, 1999).
In order to analyze the importance of the AP-1 transcription
factor in TPA-induced BSSP expression, BSSP mRNA levels were
compared between mice de®cient in one major member of AP-1
subunits, c-Fos (Wang et al, 1992), and their wild-type littermates.
As shown in Fig 3 (right panel) the basal level of BSSP expression
was even slightly increased in c-fos±/± mice and the application of
TPA onto the skin of these animals led to a strong increase in the
abundance of the BSSP mRNA, similar to the increase observed in
their wild-type littermates. These data show that c-Fos expression is
dispensable for phorbol-ester-induced upregulation of BSSP in
skin.
Glucocorticoids are known to block experimentally induced
tumorigenesis, such as phorbol-ester-mediated multistage carcino-
genesis in mouse skin (Belman and Troll, 1972). To investigate if
glucocorticoids in¯uence the phorbol-ester-mediated transcrip-
tional activation of the BSSP gene in vivo, TPA-induced expression
in skin was analyzed in the presence of the synthetic glucocorticoid
dexamethasone. Concomitant glucocorticoid treatment did not
alter the level of BSSP expression induced by TPA in wild-type
and c-Fos-de®cient mice indicating that glucocorticoids do not
transrepress the activation of the BSSP gene in mouse skin (Fig 3,
left panel).
Expression of BSSP in interfollicular epidermis and hair
follicle In order to identify the speci®c cell types in the skin
responsible for enhanced BSSP gene expression in response to
Figure 1. Identi®cation of TPA-inducible genes in murine skin
and SCC. A representative reverse northern analysis of triplicate ®lters is
shown. Each lane is loaded with 100 ng of EcoRI digested plasmid
DNAs of individual cDNA clones, derived from SSH between acetone-
treated and 6 h TPA-treated dorsal skin of adult female C57BL/6 mice.
Filters were hybridized with single-stranded 32P-labeled complex cDNA
probes of equal speci®c activity obtained from acetone-control (co) or
6 h TPA-treated (TPA) dorsal skin (n = 3) as well as from SCC (SCC;
n = 8). VL30, virus-like retrotransposon; MTI, metallothionein Ia;
BSSP, brain and skin speci®c serine protease. Expressions of the
housekeeping genes GAPDH and COX were used as internal controls
for hybridization.
Figure 2. BSSP expression in TPA-treated mouse skin. After 0
(co), 1, 2, 4, 6, and 12 h TPA-treated mice were sacri®ced and total
RNA from skin was isolated as described in Materials and Methods. BSSP
expression was analyzed by northern blot hybridization using the isolated
SSH fragment as a probe. Each lane represents RNA pooled from three
individuals. Rehybridization with a cDNA fragment of 18S RNA was
performed, serving as a loading control.
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TPA, in situ hybridization analysis on transversal sections of skin
biopsies was performed. In untreated skin speci®c signals for BSSP
expression were not detectable either in the interfollicular
epidermis (Fig 4A) or in the hair follicle (Fig 4B), whereas a
signi®cant increase in epidermal BSSP expression in epithelial cells
became visible upon phorbol ester treatment (Fig 4C). Upon TPA
treatment BSSP transcripts were also observed in keratinocytes of
the hair follicles but not in ®broblasts of the dermis (Fig 4D). In
line with the expression pattern determined by northern blot
analysis the simultaneous application of dexamethasone did not
affect TPA-induced BSSP expression in murine skin, as shown in
Figs 4(E), 4(F). Analysing the cell-type-speci®c expression of
BSSP in the skin of mice de®cient for c-Fos, no difference in
localization or strength of BSSP between wild-type and mutant
littermates (data not shown) was detectable, con®rming the results
obtained by northern blot hybridization (Fig 3).
Expression of BSSP during multistage skin
carcinogenesis As we found enhanced levels of BSSP
transcripts in RNA from SCC (Fig 1), we examined the sites of
BSSP expression during different stages of skin carcinogenesis by in
situ hybridization analysis. In hyperplastic skin, induced by chronic
treatment with TPA, BSSP expression was found predominantly in
the basal compartment of the hyperplastic epidermis 4 d after the
®nal TPA application (Figs 5A, B). This layer is characterized by a
high proliferative activity as visualized by staining for PCNA
(Fig 5C). Expression was also found in hair follicles (data not
shown). In chemically induced papillomas the strongest expression
of BSSP transcripts was also detected in the proliferatively active
basal cell layer (Fig 5D±F). Finally, in malignant SCC high levels
Figure 4. Tissue-speci®c expression of BSSP in murine dorsal skin. Acetone (A, B), TPA (C, D), as well as TPA plus dexamethasone (E, F)
were applied onto the skin of adult female C57BL/6 mice. After 6 h mice were sacri®ced; skin biopsies were taken, paraformaldehyde-®xed and
subsequently paraf®n-embedded. The SSH-derived cDNA clone of BSSP was 35S-labeled and used as a riboprobe for in situ hybridization. BSSP
expression can be detected in keratinocytes of the epidermis (ep) and hair follicle (hf), but not in ®broblasts of the dermis (de; arrows). Scale bar: 20 mm.
Figure 3. BSSP expression in the skin of c-fos-de®cient mice.
c-fos-de®cient mice (fos±/±) and their wild-type littermates (fos+/+) were
treated with acetone (co), 10 nmol TPA (TPA), or 10 nmol TPA with
50 mg dexamethasone (T + D). After 6 h mice were sacri®ced and total
RNA from skin was isolated as described in Materials and Methods. BSSP
expression was analyzed by northern blot hybridization using the isolated
SSH fragment as a probe. Each lane represents RNA pooled from three
individuals. Rehybridization with a cDNA fragment of 18S RNA was
performed, serving as a loading control.
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of BSSP transcripts were detected in keratinocytes at the edge of
proliferative carcinoma cell islets (Fig 5G±I).
DISCUSSION
In the well-characterized murine skin carcinogenesis model
phorbol esters such as TPA belong to the most potent tumor
promoters (Marks and Furstenberger, 1990). Tumorigenesis repre-
sents a complex process in which aberrant expression of cellular
genes plays a decisive role. Until now, however, only very few
TPA-inducible genes that are critically involved in skin tumor
formation and metastasis, such as mal1 (Krieg et al, 1993), transin
(Matrisian et al, 1986), MMP-9 (Coussens et al, 2000), CD44
(Herrlich et al, 1995), and urokinase plasminogen activator (Yu and
Stamenkovic, 1999), have been identi®ed. Using a combination of
SSH between control and short-term TPA-treated murine skin
with subsequent screening by reverse northern blot hybridization
we have isolated several known as well as unknown cDNAs,
representing TPA-inducible genes, which are constitutively
expressed at a late stage of carcinogenesis.
As the ®rst example of a candidate gene obtained by this fruitful
experimental strategy, here we describe the phorbol-ester-induced
expression of BSSP in murine skin. Although BSSP has been
previously described to be exclusively expressed in hair follicles of
nude mice (Meier et al, 1999) as well as in murine brain (Matsui et
al, 2000), we report here a tumor-associated expression of this
serine protease throughout the process of carcinogenesis in mouse
skin.
The transcription factors mediating BSSP activation in tissue
culture cells and in the animal have not yet been identi®ed. Our
data document transcriptional activation of BSSP upon short-term
treatment with the protein kinase C activator TPA, starting 4 h
after TPA treatment. The kinetics of BSSP induction resemble the
expression pro®les of MMP-3 and MMP-13 (Tuckermann et al,
1999), which are known to be transcriptionally regulated by AP-1
(Hu et al, 1994; Kolbus et al, 2000). Moreover, the BSSP promoter
contains a consensus binding site for AP-1 at position ±992 to ±998
relative to the putative transcriptional start site (Matsui et al, 2000).
No reduction of phorbol-ester-mediated transcriptional activation
of BSSP in skin was observed in c-Fos-de®cient mice, however,
which might argue against a critical role of AP-1 in transcriptional
regulation of BSSP. On the other hand it is also possible that other
members of the AP-1 family, which are expressed in the skin
(Welter and Eckert, 1995; Rutberg et al, 1996; Schorpp-Kistner
and Angel, unpublished), functionally compensate for the loss of c-
Fos. Alternatively, induction might be mediated by other TPA-
inducible transcription factors, such as NFkB (Nelsen et al, 1988),
which was found to exhibit high basal level activity in many late
papillomas and SCC (Budunova et al, 1999). The available
sequence of the BSSP promoter described by Matsui et al (2000),
however, does not harbour NFkB binding sites. Therefore, a
detailed analysis of deletion and point mutants of the BSSP
promoter will be required to identify the critical cis-acting elements
responsible for TPA-mediated transcriptional activation.
Although in untreated skin we and colleagues (Meier et al, 1999)
found BSSP levels to be below the level of detection, treatment of
skin with TPA for 6 h induced the expression of BSSP in
keratinocytes of the interfollicular epidermis and hair follicles.
Interestingly, a hair-follicle-speci®c expression of BSSP was
Figure 5. Expression of BSSP in hyperplastic skin as well as benign and malignant skin tumors. Sections of hyperplastic adult skin (HS) and
chemically induced papillomas (PA) and SCC (SCC) were hybridized with 35S-labeled riboprobes derived from the BSSP cDNA fragment and
photographed under dark®eld (a, d, g) and bright®eld (b, e, h) conditions. Histochemical analysis of PCNA expression was performed using a PCNA
antibody (c, f, i). ep, epidermis; bl, basal layer; st, stroma; cl, corni®ed layer; ci, carcinoma cell islet. Scale bar: 20 mm.
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reported in nude mice (Meier et al, 1999), which carry a loss-of-
function mutation in the whn gene. This gene encodes a sequence-
speci®c DNA binding protein, which is speci®cally expressed in
hair follicles (Lee et al, 1999). It is tempting to speculate that TPA
might exert its effect on BSSP expression, at least in the
keratinocytes of the hair follicle, by deactivating a Whn-mediated
inhibition of BSSP expression.
By virtue of reverse northern blot and in situ hybridization we
could document a high constitutive level expression of BSSP in
SCC of the skin. This massive increase of BSSP transcripts was
observed throughout hyperplastic, benign, as well as malignant
stages of this epithelial tumorigenesis model. As BSSP transcripts
were not detectable in untreated murine skin these data may
suggest a role of BSSP in tumorigenesis. Similar ef®ciency of TPA-
dependent, glucocorticoid-insensitive induction of BSSP in wild-
type and c-Fos-de®cient mice may argue against this hypothesis. It
is important to note that these criteria do not strictly select for
tumor-associated genes, however, because wild-type and mutant
mice do not differ in early stages of tumorigenesis, such as
hyperplasia and formation of papillomas (Saez et al, 1995). On the
other hand, established skin papillomas and SCC become resistant
to growth inhibition by glucocorticoids through downmodulation
of the glucocorticoid receptor (Budunova et al, 1997). Most
probably, tumorigenesis is a multifactorial process, where products
of AP-1-dependent and AP-1-independent genes functionally
interact in an interdependent manner and loss of expression of
genes from either category might interfere with tumorigenesis.
The predicted BSSP protein sequence indicates that BSSP is a
secreted kallikrein-like protease, showing highest homology to
human protease M, isolated from primary breast cancer cell lines
(Anisowicz et al, 1996; Meier et al, 1999). As reported for other
members of the kallikrein subfamily of serine proteases, namely
prostatic speci®c antigen and normal epithelial cell speci®c 1 gene,
which are speci®cally expressed in various cancer tissues (Diamandis
et al, 2000), human protease M is found to be overexpressed in
ovarian cancer and the colon carcinoma cell line COLO 201
(Yousef et al, 1999). As expression or activities of several proteases,
such as cathepsin D, plasminogen activator, stromelysin-1/MMP-3,
and gelatinase B/MMP-9, were found to correlate with tumori-
genic progression, particularly in breast and skin tumors (Basset et
al, 1990; Liotta and Stetler-Stevenson, 1991; Sternlicht et al, 1999;
Coussens et al, 2000), the cloning of the human BSSP homolog and
functional analysis of BSSP in various tumor models merits
enhanced effort. Proteinases play pivotal roles in altering local
microenvironments under physiologic and pathologic conditions
(formation and remodeling of extracellular matrix, angiogenesis,
and vasculogenesis; Lochter et al, 1998; Vu and Werb, 2000).
Moreover, BSSP, as shown for many other proteases, may
participate in the activation of hormones and growth factors by
proteolytic cleavage of inactive proforms (Matrisian and Hogan,
1990).
Nonmelanoma skin cancers are known to arise from the
transformation of basal keratinocytes either of the interfollicular
epidermis or of the hair follicle (Taylor et al, 2000). Whereas in
untreated murine skin BSSP mRNA was not detectable, we
observed constitutive BSSP expression not only in keratinocytes of
hyperplastic skin, malignant tumors, and papillomas, but also after a
single treatment with the tumor promoter TPA in keratinocytes of
the interfollicular epidermis as well as in the hair follicle, indicating
a role of BSSP already in the early stages of the tumorigenic process.
Interestingly, in a keratinocyte cell line isolated from DMBA-
initiated skin (MCA 3D) TPA faintly induces the expression of
BSSP transcripts, and in cell derivatives expressing an oncogenic
version of Ras (MCA AT3) both basal and TPA-induced levels are
further increased (data not shown).
Furthermore, we found a massive expression of BSSP at late
stages of the tumorigenesis process in skin. The restriction of BSSP
expression to proliferatively potent basal keratinocytes at the front
of carcinoma cell islets in skin is intriguing and suggests a direct or
indirect function of this protease in the proteolytic cascade leading
to degradation of the extracellular matrix. In accordance with this
idea recombinantly expressed BSSP was shown to degrade
®bronectin and gelatine (Matsui et al, 2000). In light of the
proposed function of BSSP in the extracellular space (Meier et al,
1999) it is tempting to speculate that BSSP may also contribute to
the invasive and metastatic potential of tumor cells.
The characterization of BSSP as a serine protease expressed
throughout the process of skin carcinogenesis adds another member
to a group of kallikrein-like proteases that may participate in a
cascade mechanism of enzymatic reactions resulting in the degrad-
ation of extracellular matrix components or liberation of bioactive
peptides or polypeptides. Based on its structural characteristics and
expression pattern in cancer tissues it will be important to precisely
de®ne the role of BSSP in cell transformation, angiogenesis, tumor
progression, and invasion. These data, together with the identi®-
cation of BSSP activators and targets, may help to establish BSSP as
a diagnostic or therapeutic target for the treatment of at least skin
cancer.
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